津药药业
(600488)
| 流通市值：45.53亿 | | | 总市值：45.53亿 |
| 流通股本：10.92亿 | | | 总股本：10.92亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 738,844,228.67 | 638,455,967.29 | 818,431,766.55 | 728,317,437.3 |
| 应收票据及应收账款 | 426,084,165.89 | 292,323,794.07 | 335,358,496.24 | 441,484,294.35 |
| 其中：应收票据 | 0 | 1,085,411.71 | - | - |
| 应收账款 | 426,084,165.89 | 291,238,382.36 | 335,358,496.24 | 441,484,294.35 |
| 应收款项融资 | 165,478,500.51 | 166,797,324.1 | 149,788,605.04 | 137,749,102.75 |
| 预付款项 | 18,055,225.85 | 22,502,776.16 | 33,580,766.51 | 30,129,787.59 |
| 其他应收款合计 | 30,474,492.51 | 25,207,367.28 | 28,478,368.88 | 33,504,005.53 |
| 存货 | 665,055,904.34 | 651,915,382.71 | 749,029,454.24 | 795,589,493.06 |
| 其他流动资产 | 7,244,123.46 | 7,256,357.65 | 1,553,057.42 | 4,554,102.63 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,051,236,641.23 | 1,804,458,969.26 | 2,116,220,514.88 | 2,171,328,223.21 |
| 非流动资产: | | | | |
| 长期股权投资 | 13,170,646.12 | 13,614,309.65 | 22,683,604.97 | 23,531,110.51 |
| 其他权益工具投资 | 214,879,638.4 | 214,266,894.41 | 145,485,016.79 | 144,820,791.38 |
| 固定资产 | 2,766,987,573.9 | 2,830,190,701.19 | 2,881,157,588.31 | 2,915,911,896.21 |
| 在建工程 | 40,208,551.48 | 44,520,198.56 | 27,539,717.3 | 35,368,063.79 |
| 使用权资产 | 246,709.42 | 287,827.66 | 0 | 42,285.61 |
| 无形资产 | 349,960,260.6 | 349,664,194.85 | 331,478,028.34 | 311,993,533.09 |
| 开发支出 | 183,911,675.91 | 180,910,527.41 | 173,829,566.71 | 172,594,190.8 |
| 递延所得税资产 | 28,096,315.84 | 28,878,143.76 | 36,444,954.62 | 38,311,282.71 |
| 其他非流动资产 | 229,378,831.8 | 231,494,606.4 | 254,975,359.61 | 289,429,440.68 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,826,840,203.47 | 3,893,827,403.89 | 3,873,593,836.65 | 3,932,002,594.78 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 5,878,076,844.7 | 5,698,286,373.15 | 5,989,814,351.53 | 6,103,330,817.99 |
| 流动负债: | | | | |
| 短期借款 | 125,711,648.86 | 108,576,306.93 | 93,077,721.08 | 81,735,459.37 |
| 应付票据及应付账款 | 725,317,075.05 | 638,693,043.34 | 722,209,777.83 | 850,220,275.75 |
| 其中：应付票据 | 131,918,272 | 109,807,372 | 126,141,732.85 | 141,656,665.22 |
| 应付账款 | 593,398,803.05 | 528,885,671.34 | 596,068,044.98 | 708,563,610.53 |
| 预收款项 | 37,625.86 | 7,093.09 | 148,735.06 | 477,823.16 |
| 合同负债 | 45,430,745.08 | 79,725,334.68 | 87,178,812.3 | 90,202,823.48 |
| 应付职工薪酬 | 74,579,858.23 | 132,891,919.16 | 94,475,906.15 | 79,330,035.27 |
| 应交税费 | 18,334,327.84 | 25,398,657.44 | 28,739,561.35 | 33,530,469.94 |
| 其他应付款合计 | 206,738,126.61 | 220,143,497.14 | 249,927,429.23 | 267,043,139.93 |
| 应付股利 | 47,370.4 | 47,370.4 | 47,370.4 | 283,563.61 |
| 一年内到期的非流动负债 | 7,988,033.32 | 702,900.72 | 149,700,826.39 | 306,736,194.54 |
| 其他流动负债 | 3,859,101.57 | 8,857,039.38 | 8,239,659.81 | 9,974,315.38 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,207,996,542.42 | 1,214,995,791.88 | 1,433,698,429.2 | 1,719,250,536.82 |
| 非流动负债: | | | | |
| 长期借款 | 537,360,000 | 424,600,000 | 529,700,000 | 373,469,443 |
| 租赁负债 | 71,171.13 | 113,576.86 | - | - |
| 长期应付职工薪酬 | 3,449,000 | 3,449,000 | 8,060,000 | 8,060,000 |
| 递延收益 | 137,462,577.91 | 140,830,403.12 | 142,829,732.38 | 144,875,044.84 |
| 递延所得税负债 | 27,783,028.03 | 27,957,944.34 | 17,785,190.25 | 17,962,852.49 |
| 其他非流动负债 | 475,577.36 | 475,577.36 | 713,366.04 | 713,366.04 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 706,601,354.43 | 597,426,501.68 | 699,088,288.67 | 545,080,706.37 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,914,597,896.85 | 1,812,422,293.56 | 2,132,786,717.87 | 2,264,331,243.19 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,091,886,680 | 1,091,886,680 | 1,091,886,680 | 1,093,932,680 |
| 资本公积 | 320,480,720.37 | 320,316,177.46 | 320,378,322.11 | 322,190,215.52 |
| 减:库存股 | - | 0 | 0 | 4,726,260 |
| 其他综合收益 | 108,987,105.97 | 108,540,240.48 | 49,704,154.74 | 49,658,370.14 |
| 专项储备 | 4,415,835.34 | 2,872,548.18 | 2,153,415.02 | 1,199,938.05 |
| 盈余公积 | 247,923,080.79 | 247,923,080.79 | 237,483,087.4 | 248,417,943.85 |
| 未分配利润 | 1,343,858,486.19 | 1,285,808,360.27 | 1,349,493,097.52 | 1,293,634,334.92 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,117,551,908.66 | 3,057,347,087.18 | 3,051,098,756.79 | 3,004,307,222.48 |
| 少数股东权益 | 845,927,039.19 | 828,516,992.41 | 805,928,876.87 | 834,692,352.32 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,963,478,947.85 | 3,885,864,079.59 | 3,857,027,633.66 | 3,838,999,574.8 |
| 负债和股东权益合计 | 5,878,076,844.7 | 5,698,286,373.15 | 5,989,814,351.53 | 6,103,330,817.99 |
| 公告日期 | 2025-04-29 | 2025-03-27 | 2024-10-30 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |